Intravenous injection of sheep erythrocytes into normal immunologically competent C57BI/6J mice results in significant and characteristic changes in the splenic level of 3':5'-cAMP with initiation of the immune response and proliferation of antibody-forming cells. The level increases 2-to 3-fold initially, peaks at 2 min, and returns to base level in an hour. Between 2 and 5 days there is a decrease, followed by a peak when the rate of proliferation of antibody-forming cells is maximal. Changes in splenic level of cAMP are thus transitory and biphasic, and they occur only in response to foreign substances that are immunogenic, such as heterologous erythrocytes, and not to antigenically inert carbon particles. They are also dependent upon the dose of immunogen. Moreover, the double-stranded hybrid of polyadenylate and polyuridylate, which acts synergistically with antigen in stimulating endogenous cAMP, is immunoenhancing if given with sheep erythrocytes when the cAMP level is increasing, and immunosuppressive if given when cAMP is decreasing. These data provide direct evidence for a role of cAMP as a mediator in the activation and proliferation of immunocytes stimulated by antigen. With knowledge of the transitory and biphasic nature of the cAMP response induced by antigen, one can avoid indiscriminate use of drugs that modify the level of endogenous cAMP and instead employ them rationally in controlling the immune response, enhancing or suppressing it as desired.
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With the discovery that cAMP acts as a second "messenger" in regulating hormone-dependent cellular processes, such as differentiation, proliferation, and function (1, 2) , attention inevitably turned to the possible role of cAMP in antigendependent cellular events. There is now much evidence that cAMP is a protagonist in the activation and functioning of immunocytes responding to antigen (3, 4) . The evidence with respect to activation is largely indirect and is based on the effect of stimulators of biosynthesis of endogenous cAMP on the immune response to antigens. One interpretation of this effect is that antigen itself, on reacting with immunocytes, normally stimulates biosynthesis of endogenous cAMP and that stimulators act synergistically with antigen to increase the cellular concentration of cAMP to the level of an activation signal. In this case, one would predict significant changes in the cAMP level of lymphoid organs, such as the spleen, of animals during their response to antigen under physiological conditions. We have been able to verify this prediction by quantitating cAMP in the spleen of mice as they responded to sheep erythrocytes as antigens. Poly(A) Poly(U). This double-stranded hybrid of the homopolymers polyriboadenylate and polyribouridylate is known to be an immunoenhancing agent (9) . Purchased from Miles Labs, Elkhart, Ind., it was dissolved in pyrogenfree saline for use. If the cells contributing to the changes in the level of cAMP included immunocytes responding to antigen, one would expect some correlation between the time of cAMP change and specific temporal events in antibody formation, beginning with the activation of antigen-processing and helper T-cells (thymus-processed) and ending with proliferation of activated antibody-producing cells. Each group of animals also included, therefore, mice whose spleens were assayed for antibody-producing plaque-forming cells (PFC). From the results, in Fig. 2 , it is apparent that the period during which the cAMP level is decreasing (compare Fig. 1 ) is coincident with the period of peak proliferation of PFC. The earlier change in splenic level of cAMP seems to be associated with activation of helper T-cells, since Plescia and Hirsch (10) found that functional antigen-carrying T-cells begin to appear in the spleens of mice responding to sheep erythrocytes shortly after the increase in cAMP has occurred. The number of such cells peaked at about 4 hr, while the cAMP increase peaked at about 15 min when sheep erythrocytes were injected intraperitoneally. (Fig. 3) . A plateau was reached at about 109 sheep erythrocytes, and a point of inflection in the curve was seen at 3 X-108 sheep erythrocytes, which was adopted as the standard dose in subsequent experiments on the interaction of antigen with host cells resulting in elevation of cAMP in the spleen. Specificity of the Response. As a test of specificity, erythrocytes of syngeneic and allogeneic origin were compared with sheep erythrocytes for ability to stimulate biosynthesis of endogenous cAMP. Control mice were given diluent. At 2 min, Groups consisting of five mice were injected with erythrocytes from each species. Two min after injection all animals were sacrificed and their spleens were excised for assay of cAMP. Each value is the mean of 5 aliquots of a pool of the spleens in the group.
Effect of poly(A) poly(U) on cAMP response and antibody formation
If, as the above data indicate, the changes in endogenous cAMP are due to antigen-reactive cells participating in the immune response to sheep erythrocytes, it follows that agents such as poly(A) * poly(U), which stimulates the antibody response to sheep erythrocytes (9), might affect the cAMP response. This proved to be true; addition of poly(A) -poly(U) to sheep erythrocytes resulted in greater elevation of the cAMP level in the spleen at 2 min (Fig. 4) . The poly(A) -poly-(U) seems to act synergistically with sheep erythrocytes in increasing the level of cAMP because poly(A) -poly(U) alone produces no significant change (data not shown).
In view of this finding, and assuming a relationship between the decrease in cAMP and proliferation of antibody-inducing cells starting on day 2, it could be predicted that poly(A) -poly-(U) would be immunosuppressive if given on day 2 relative to the administration of sheep erythrocytes. This was tested by immunization of groups of mice with sheep erythrocytes and giving poly(A) poly(U), except for the controls, at different times. Fourteen days after antigen was injected, all mice were sacrificed and their spleens were assayed for PFC.
The prediction was proved to be correct (Table 2 ). Poly(A). poly(U) stimulated maximally the antibody response when given together with antigen, when the cAMP level in response to antigen was increasing, and it suppressed the antibody response when given when the cAMP level was decreasing.
DISCUSSION
The immune response of mice to sheep erythrocytes, under normal physiological conditions, is accompanied by significant changes in the level of cAMP in the spleen. competition between carbon and sheep erythrocytes, it is also evident that phagocytic cells are not involved in the response to cAMP, a conclusion supported by the recent report that cAMP is not the chemical mediator of metabolic changes accompanying phagocytosis (11) .
Evidence of a link between the late change in the splenic level of cAMP and proliferation of antibody-producing cells was first suggested by the coincidence of the time during which both events occurred (Figs. 1 and 2 ). More definitive evidence is furnished by the finding that poly(A)-poly(U), which acts synergistically with antigen to stimulate synthesis of endogenous cAMP, is both immunosuppressive and immunoenhancing, depending upon the time of its administration relative to antigen ( Table 2 ). It enhances antibody formation at a time when the cAMP level is increasing, and it suppresses when the cAMP level is decreasing. Both activities of poly-(A) -poly(U) are maximal when it is injected at the time the change in level of cAMP is just beginning.
Two features with respect to cAMP characterize the response of mice to antigen. First, the change in level of cAMP, both early and late, is transitory, and second, it is biphasic, since the level increases in the early phase and decreases in the later phase. Teh and Paetkau (12) , in studying the effect of adding an inhibitor of cAMP-phosphodiesterase at different times during the in vitro antibody response of mouse spleen cells to sheep erythrocytes, indirectly showed the same features. The clear implication of these characteristics is that agents that stimulate biosynthesis of cAMP or inhibit cAMP-phosphodiesterase can be both immunoenhancing and immunosuppressive, depending upon the relative timing of their administration, and that such agents should not be used indiscriminately in the control of the immune system. We now can understand why in previous studies the activity of poly(A) poly(U), in enhancing the immunity of mice to syngeneic tumors, varied with the timing and number of injections of poly(A) -poly(U) given (W. Braun and 0. J. Plescia, unpublished results).
Our results now provide direct evidence that antigen itself, without any other external intervention, induces changes in the endogenous level of cAMP which are linked to the activation of the immune system. Moreover, having characterized the transitory and biphasic nature of the cAMP response, we should be better able to'exploit drugs that can modify the level of endogenous cAMP, as a means of controlling the immune system.
